TGX-221
TGX-221, an effective, specific, and cell membrane permeable inhibitor of the PI3K p110β catalytic subunit, is utilized for cancer treatment.
| Catalog Number | T2661 |
| Alternative Name(s) | TGX221 |
| Research Area | PI3K/Akt/mTOR signaling |
| Molecular Formula | C21H24N4O2 |
| CAS# | 663619-89-4 |
| Purity | 98.98% |
| SMILES | CC(Nc1ccccc1)c1cc(C)cn2c(=O)cc(nc12)N1CCOCC1 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/TGX-221 |
| Additional Information | https://www.targetmol.com/datasheet/T2661 |